Enhancing TSH-based congenital hypothyroidism screening using machine learning and resampling algorithms

Alexander De Furia1,2, Paula Branco3, Matthew Henderson4,5

  • 1School of Electrical Engineering and Computer Science, University of Ottawa, 800 King Edward Ave., Ottawa, Ontario, K1N 5N6, Canada. adefu020@uottawa.ca.

Insights

Machine learning significantly improves congenital hypothyroidism screening by boosting positive predictive value 60% while maintaining 100% sensitivity. This advanced approach reduces false positives and unnecessary diagnostic costs for newborns.

Area of Science:

  • Medical screening
  • Machine learning applications
  • Neonatal health

Background:

  • Congenital hypothyroidism (CH) is a leading cause of preventable intellectual disability.
  • Current newborn screening for CH relies on thyroid-stimulating hormone (TSH), facing challenges with low positive predictive value (PPV).
  • Previous machine learning attempts for CH screening were hindered by data imbalance and limited predictive features.

Purpose of the Study:

  • To conduct a comprehensive evaluation of machine learning algorithms for congenital hypothyroidism screening.
  • To address the limitations of current TSH-based screening methods, specifically low PPV.
  • To develop a more accurate and efficient screening model for CH.

Main Methods:

  • Analysis of data from 616,910 infants screened between 2019 and 2024.
  • Training and evaluation of 576 distinct machine learning models using 12 classification and 12 resampling algorithms.
  • Optimization for sensitivity and PPV using stratified 5-fold cross-validation and assessment of model explainability via SHAP values.

Main Results:

  • A RUSBoost classifier with Gaussian Noise resampling achieved 100% sensitivity and 16.8% PPV.
  • This represents a 60% improvement in PPV compared to current screening approaches.
  • TSH remained the primary predictor, but the model incorporated additional features to enhance performance.

Conclusions:

  • Machine learning models demonstrated no missed cases of CH and significantly improved screening performance.
  • These algorithms offer a promising alternative to refine TSH-based CH screening.
  • The findings suggest potential for reducing false positives, stress, and costs in global newborn screening programs.
Abstract